Sign in
Facet browsing currently unavailable
Page 2 of 181 results
Sort by: relevance publication year
|
Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib JOURNAL ARTICLE published October 2017 in Lung Cancer: Targets and Therapy |
|
Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma JOURNAL ARTICLE published August 2016 in Lung Cancer: Targets and Therapy |
|
AXL receptor tyrosine kinase as a therapeutic target in NSCLC JOURNAL ARTICLE published April 2015 in Lung Cancer: Targets and Therapy |
|
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer JOURNAL ARTICLE published November 2017 in Lung Cancer: Targets and Therapy |
|
Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity JOURNAL ARTICLE published July 2017 in Lung Cancer: Targets and Therapy |
|
Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives JOURNAL ARTICLE published March 2018 in Lung Cancer: Targets and Therapy |
|
High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells JOURNAL ARTICLE published May 2016 in Lung Cancer: Targets and Therapy |
|
Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer JOURNAL ARTICLE published November 2023 in Lung Cancer: Targets and Therapy |
|
<p>Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date</p> JOURNAL ARTICLE published September 2019 in Lung Cancer: Targets and Therapy |
|
Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation JOURNAL ARTICLE published May 2022 in Lung Cancer: Targets and Therapy |
|
Co-Occurring EGFR S645C and EGFR L858R in a Patient with Lung Adenocarcinoma Induced Primary Resistance to Osimertinib JOURNAL ARTICLE published October 2023 in Lung Cancer: Targets and Therapy |
|
Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer JOURNAL ARTICLE published December 2017 in Lung Cancer: Targets and Therapy |
|
Stage as the Sole “Biomarker” for Adjuvant Pembrolizumab in Resected Stage IB to IIIA NSCLC without Considerations for PD-L1 Expression Level, ALK/EGFR Mutational Status, and Prior Adjuvant Chemotherapy per FDA Approval Indications of PEARLS/Keynote-091? JOURNAL ARTICLE published December 2023 in Lung Cancer: Targets and Therapy |
|
Staging lung cancer: role of endobronchial ultrasound JOURNAL ARTICLE published November 2014 in Lung Cancer: Targets and Therapy |
|
An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer JOURNAL ARTICLE published August 2021 in Lung Cancer: Targets and Therapy |
|
<p>Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis</p> JOURNAL ARTICLE published January 2019 in Lung Cancer: Targets and Therapy |
|
Bevacizumab in the treatment of NSCLC: patient selection and perspectives JOURNAL ARTICLE published December 2017 in Lung Cancer: Targets and Therapy |
|
Lung cancer in women JOURNAL ARTICLE published December 2012 in Lung Cancer: Targets and Therapy |
|
Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond JOURNAL ARTICLE published August 2013 in Lung Cancer: Targets and Therapy |
|
The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers JOURNAL ARTICLE published December 2021 in Lung Cancer: Targets and Therapy |